SichuanPeople’s Republic of ChinaAsi aAdenocarcinomaAlgorithmsCOVID-19CancerCoronavirusCyborgsDrugs and TherapiesEmerging TechnologiesGeneticsHealth and MedicineImmunologyIm munotherapyLung CancerLung Diseases and ConditionsMachine LearningMortal ityOncologyPersonalized MedicinePersonalized TherapyRNA VirusesRespira tory Tract Diseases and ConditionsRisk and PreventionSARSSARS-CoV-2Sever e Acute Respiratory SyndromeSevere Acute Respiratory Syndrome Coronavirus 2T herapeuticsTherapyViralVirology
2024